11/18/2020 | IGLM | Pfizer to fully redeem 5.8% notes due 2023, 1.95% notes due 2021
|
5/22/2020 | IGLM | Pfizer, Wyeth recommend rejecting tender offer made by Huguenot
|
3/5/2019 | BKIGLM | Pfizer to refinance, redeem or buy back debt via $5 billion issue
|
12/7/2018 | EULM | Pfizer to redeem €1.14 billion of 5.75% notes due 2021 on Jan. 9
|
1/8/2018 | EULM | Pfizer gets tenders for €24.7 million more 5.75% notes, lacks consents
|
12/21/2017 | EULM | Pfizer prices 5.75% note tender, gives response, waives consent test
|
12/15/2017 | EULM | Pfizer to issue £1.38 billion 2.735% notes in exchange, takes in tenders for £196.55 million
|
12/14/2017 | IGLM | Pfizer to issue 2.735% notes due 2043 in exchange; cash offer prices
|
12/7/2017 | IGLM | Pfizer holds exchange, cash offers for 6.5% notes due 2038, tender for 5.75% notes due 2021
|
11/21/2016 | IGLM | Pfizer holders tender $1.94 billion of 6.2% notes due 2019 in offer
|
11/18/2016 | IGLM | Pfizer prices tender offer for $3.25 billion of 6.2% notes due 2019
|
11/14/2016 | IGLM | Pfizer begins tender for $3.25 billion of 6.2% senior notes due 2019
|
11/10/2015 | HYLM | Pharmaq exercises call on senior secured floating-rate bonds due 2019
|
10/2/2015 | IGLM | Pfizer wraps exchange for four series of Hospira notes after buyout
|
9/18/2015 | IGLM | Pfizer gives early tender update in exchange offers for Hospira notes
|
9/4/2015 | IGLM | Pfizer begins exchange offers, consent solicitations for Hospira notes
|
11/14/2013 | IGLM | Pfizer subsidiary to redeem all $1.75 billion of 5.5% notes due 2014
|
8/28/2012 | IGLM | Pfizer lacks needed consents from holders of two Pharmacia note series
|
8/15/2012 | IGLM | Pfizer solicits consents to amend five series of Pharmacia debentures
|
3/1/2011 | CVLM | King Pharmaceuticals holders put $397.31 million 1.25% convertibles
|
1/31/2011 | CVLM | King tenders for all $400 million of 1.25% convertible notes due 2026
|